Skip to content

    BeOne Medicines Ltd.

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $929.17M
    $1.00B
    $1.13B
    $1.12B
    $1.32B
    +41.6%
    $1.41B
    +41.0%
    $1.50B
    +32.8%
    $1.51B
    +35.5%
    Strengthening
    Operating Profit
    -$107.16M
    -$120.27M
    -$79.42M
    $11.10M
    $87.89M
    $163.11M
    $185.03M
    $249.90M
    +2151.0%
    Strengthening
    Net Profit
    -$120.41M
    -$121.35M
    -$151.88M
    $1.27M
    $94.32M
    $124.84M
    $66.50M
    $227.36M
    +17802.1%
    Strengthening
    EPS
    $-0.09
    $-0.09
    $0.00
    $0.07
    $0.09
    $0.16
    Strengthening
    Other Income
    Interest
    $7.00M
    $32.89M
    +369.7%
    Strengthening
    Depreciation
    Profit before Tax
    -$105.92M
    -$98.30M
    -$85.35M
    $20.90M
    $99.55M
    $147.16M
    $149.24M
    $259.21M
    +1140.3%
    Strengthening
    MarginsOPM
    -11.5%
    -12.0%
    -7.0%
    1.0%
    6.7%
    11.6%
    12.3%
    16.5%
    +1567.7%
    Strengthening
    Tax
    -13.7%
    -23.4%
    -78.0%
    93.9%
    5.3%
    15.2%
    55.4%
    12.3%
    -86.9%
    Weakening
    ReturnsROIC
    1.5%
    1.5%
    1.9%
    -0.0%
    -1.2%
    -178.3%
    -1.5%
    -202.9%
    -0.8%
    -143.8%
    -2.8%
    -17802.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$712.94M$618.01M$1.38B$4.38B$3.87B$3.17B$2.63B$4.55B$4.79B
    Short-Term Investments
    Total Current Assets$1.94B$1.17B$4.96B$7.61B$5.21B$4.20B$3.99B$6.23B$6.60B
    Net PP&E$202.12M$324.92M$448.27M$705.04M$955.91M$1.42B$1.72B$1.79B$1.79B
    Goodwill$109.0K$109.0K$109.0K$109.0K$109.0K
    Intangibles$7.17M$5.85M$5.00M$46.68M$40.62M$57.14M$51.09M$62.70M$61.68M
    Total Assets$2.25B$1.61B$5.60B$8.54B$6.38B$5.81B$5.92B$8.19B$8.55B
    LiabilitiesTotal Current Liabilities$246.45M$310.31M$1.08B$1.60B$1.47B$1.81B$2.21B$1.83B$1.81B
    Short-Term Debt$8.73M$0$335.01M$427.56M$328.97M$688.37M$851.53M$57.29M$116.14M
    Long-Term Debt$40.78M$83.31M$183.64M$202.11M$209.15M$197.62M$166.48M$961.91M$962.51M
    Long-Term Leases$25.83M$29.42M$43.04M$34.52M$22.25M$44.28M$52.94M$49.67M
    Total Liabilities$496.04M$633.93M$1.73B$2.40B$2.00B$2.27B$2.59B$3.83B$3.79B
    EquityCommon Stock & APIC$77.0K$79.0K$118.0K$133.0K$135.0K$135.0K$138.0K$144.0K$144.0K
    Retained Earnings-$1.01B-$1.96B-$3.55B-$5.08B-$7.08B-$7.96B-$8.61B-$8.32B-$8.09B
    Total Equity$1.74B$962.21M$3.87B$6.13B$4.38B$3.54B$3.33B$4.36B$4.76B
    HighlightsNet Cash / (Debt)$663.42M$534.70M$863.30M$3.75B$3.33B$2.29B$1.61B$3.53B$3.71B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$547.72M-$750.27M-$1.28B-$1.30B-$1.50B-$1.16B-$140.63M$1.13B$1.28B
    Cash from Investing-$637.61M$554.16M-$3.17B$640.66M$1.08B$60.00M-$548.35M-$276.15M-$199.72M
    Cash from Financing$1.69B$85.68M$5.20B$3.64B-$18.97M$416.48M$193.45M$1.06B$1.16B
    SummaryCapital Expenditure-$70.28M-$89.61M-$117.51M-$262.94M-$325.43M-$561.90M-$492.66M-$185.84M-$170.22M
    Free Cash Flow-$618.00M-$839.88M-$1.40B-$1.56B-$1.82B-$1.72B-$633.29M$941.74M$1.11B
    FCF Margin-311.8%-196.1%-453.6%-132.8%-128.7%-69.9%-16.6%17.6%19.4%